Transcend Capital Advisors LLC Reduces Stock Position in Colgate-Palmolive (NYSE:CL)

Transcend Capital Advisors LLC cut its holdings in Colgate-Palmolive (NYSE:CL) by 2.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 18,028 shares of the company’s stock after selling 421 shares during the period. Transcend Capital Advisors LLC’s holdings in Colgate-Palmolive were worth $1,639,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Chicago Partners Investment Group LLC raised its position in shares of Colgate-Palmolive by 16.2% during the 4th quarter. Chicago Partners Investment Group LLC now owns 6,752 shares of the company’s stock worth $591,000 after acquiring an additional 943 shares in the last quarter. Peak Financial Advisors LLC purchased a new position in Colgate-Palmolive in the fourth quarter valued at approximately $1,315,000. Gordian Advisors LLC acquired a new stake in Colgate-Palmolive during the third quarter worth approximately $602,000. Carrera Capital Advisors lifted its position in shares of Colgate-Palmolive by 23.1% during the 3rd quarter. Carrera Capital Advisors now owns 39,170 shares of the company’s stock worth $4,066,000 after buying an additional 7,353 shares during the last quarter. Finally, Fiduciary Alliance LLC acquired a new position in shares of Colgate-Palmolive in the 4th quarter valued at $4,066,000. 80.41% of the stock is owned by hedge funds and other institutional investors.

Colgate-Palmolive Trading Up 1.9 %

Shares of Colgate-Palmolive stock opened at $89.56 on Friday. The firm has a market cap of $72.68 billion, a price-to-earnings ratio of 25.44, a price-to-earnings-growth ratio of 4.18 and a beta of 0.44. Colgate-Palmolive has a 52-week low of $84.45 and a 52-week high of $109.30. The company’s 50-day simple moving average is $88.94 and its 200-day simple moving average is $95.91. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period last year, the firm posted $0.87 EPS. As a group, equities research analysts anticipate that Colgate-Palmolive will post 3.75 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st were given a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 2.23%. The ex-dividend date was Tuesday, January 21st. Colgate-Palmolive’s payout ratio is 56.82%.

Wall Street Analysts Forecast Growth

CL has been the topic of several research analyst reports. UBS Group cut their price target on shares of Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating on the stock in a research note on Monday, February 3rd. Piper Sandler cut their target price on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research report on Monday, January 6th. Wells Fargo & Company reduced their target price on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a report on Tuesday, January 7th. Morgan Stanley dropped their price target on Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating on the stock in a research note on Monday, February 3rd. Finally, Royal Bank of Canada reiterated a “sector perform” rating and issued a $101.00 price objective on shares of Colgate-Palmolive in a research note on Wednesday, January 29th. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $101.16.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.